Testing Status of Retinoid project 1 M930087

 

CASRN: RETINOID1

Formula: NA

Secondary:

  • 514-78-3 - Canthaxanthin
  • 65646-68-6 - 4-(Hydroxyphenyl)retinamide
  • 65646-68-6 - Retinoid project 2 (4-(Hydroxyphenyl)retinamide)
  • 127-47-9 - Retinoid project 3 (Retinol acetate)
  • 65646-68-6 - Retinoid project 4 (4-(Hydroxyphenyl)retinamide)
  • 65646-68-6 - Retinoid project 5 (4-(Hydroxyphenyl)retinamide)
  • 65646-68-6 - Retinoid project 6 (4-HPR)
  • 127-47-9 - Retinol acetate
  • 68-26-8 - All-trans retinol

Known Uses

Project combining various retinoids to examine their use in the prevention and intervention of breast cancer

Short-Term Toxicity

  • 26 weeks (Dosed-Feed)  (C93028)  Completed 
    • Citation: Rao G, Ney E, Herbert R. Changes associated with delay of mammary cancer by retinoid analogues in transgenic mice bearing c-neu oncogene. Breast Cancer Research and Treatment 58:241-254. (2000)
    • Citation: Rao G, Ney E, Herbert R. Effect of retinoid analogues on mammary cancer in transgenic mice with c-neu breast cancer oncogene. Breast Cancer Research and Treatment 48:265-271. (1998)
    • Citation: Rao G, Ney E, Herbert R. Influence of Diet on Mammary Cancer in Transgenic Mice Bearing an Oncogene Expressed in Mammary Tissue.
    • Mice: MMTV/NEU (Tg.Nk)